Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Medicare Part B: Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries
James Cosgrove (au)
Some of the drugs approved in recent years by the Department of Health and Human Servicesäó» (HHSäó») Food and Drug Administration (FDA) have been associated with high spending. This report provides information on trends in the costs of newly approved drugs in the Medicare Part B program and the potential implications of these costs for the Medicare program and its beneficiaries. The report (1) describes the drugs newly approved by FDA and paid for by Medicare Part B and compares them to drugs newly approved and not paid for by Part B; and (2) examines, for new Part B drugs, patterns of Medicare expenditures, including overall Part B expenditures and expenditures per beneficiary, and utilization. Tables. This is a print on demand report.
Woman’s Guide to Making Therapy Work
Skin Deep: Black Women & White Women Write About Race
Just Horses: Living with Horses in America
Rise of Life: The First 3.5 Billion Years
Guide to Homoeopathy
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.